Huber Martin H. Jr. insider trades
Huber Martin H. Jr. has filed 25 Form 4s with the SEC that we hold, for MRSN (President, CEO, Director), Syndax Pharmaceuticals Inc (SNDX) (Director), Xilio Therapeutics, Inc. (XLO) (PRESIDENT AND HEAD OF R&D) and Actuate Therapeutics, INC. (ACTU) (Director). Across all of them we count 1 purchase worth $45.0K and 3 sales worth $106.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 50,423 shares of MRSN worth $88.7K, dated 2024-09-12. The first filing on our record is dated 2021-09-17 and the latest 2026-05-22.
MRSN
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-12 | S, sale reported on Form 4 | 50,423 | $88.7K | 2024-09-13 |
| 2025-01-16 | S, sale reported on Form 4 | 4,514 | $2.6K | 2025-01-17 |
| 2025-09-12 | S, sale reported on Form 4 | 2,012 | $14.7K | 2025-09-15 |
Syndax Pharmaceuticals Inc (SNDX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-05-19 | P, purchase reported on Form 4 | 5,000 | $45.0K | 2025-05-19 |
Xilio Therapeutics, Inc. (XLO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Actuate Therapeutics, INC. (ACTU)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1653276) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms